Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are pleased to announce that Professor Sir John Bell has been selected for induction into the Canadian Medical Hall of Fame, for his pioneering advances in the era of translation research, bringing ground-breaking laboratory discoveries into the world of practical medicine.

Professor Sir John Bell © Canadian Medical Hall of Fame

Canadian Medical Hall of Fame Laureates are Canadian citizens whose outstanding leadership and contributions to medicine and the health sciences, in Canada or abroad, have led to extraordinary improvements in human health. Their work may be a single meritorious contribution or a lifetime of superior accomplishments. Pioneers in their field, they are role models who inspire young Canadians to pursue careers in the health sciences. "The Canadian Medical Hall of Fame is proud to welcome these six individuals whose outstanding contributions to health have made Canada, and the world, a better place," said Dr. William L. Orovan Chair of the Canadian Medical Hall of Fame. "Their impact is well documented, and they have earned their place alongside our 143 Laureates.

Read more on the Canadian Medical Hall of Fame website

Similar stories

Wearing face coverings protected wearers from COVID-19 infection – large scale study

People who wore face coverings or masks outside of the home, and were more exposed to infection due to their circumstances, had ‘significantly’ lower rates of COVID-19 infection, according to research published in BMJ Open today, led by Oxford’s Leverhulme Centre for Demographic Science.

Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s

A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.

Oxford researchers awarded funding to complete community COVID-19 antiviral trial

Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.